secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0000950170-24-064571
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Appoints Kevin Coop as CEO effective June 24; Founder Krantz remains Executive Chairman
--------------------------------------------------------------------------------

- Kevin Coop appointed CEO effective June 24, 2024; founder Jason Krantz steps down as interim CEO but stays as Executive Chairman.
- Coop receives base salary $500k, target bonus 100%, initial RSU grant of $7.5M value, and performance PSUs with stock price hurdles $10-$27.
- At annual meeting, stockholders elected three Class III directors, ratified Deloitte as auditor, and approved say-on-pay on a non-binding basis.
- 2023 Inducement Plan amended to increase reserved shares to 4.4 million for the inducement grants to Coop.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024064571/0000950170-24-064571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024064571/dh-20240520.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-064571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer